Heron Therapeutics
HRTX
HRTX
152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more funds holding
Funds holding: 124 → 152 (+28)
18.42% more ownership
Funds ownership: 107.15% → 125.57% (+18%)
10% more call options, than puts
Call options by funds: $39.4M | Put options by funds: $35.7M
Holders
152
Holding in Top 10
8
Calls
$39.4M
Puts
$35.7M
Top Buyers
| 1 | +$60M | |
| 2 | +$54.2M | |
| 3 | +$50M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$42.2M |
| 5 |
BM
Bridger Management
New York
|
+$35.3M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$31.8M | |
| 3 | -$19M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.2M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$15M |